Alternating electric field therapy, sometimes called tumor treating fields, or TTFields, is a type of electromagnetic field therapy using low-intensity electrical fields to treat cancer.
A TTF-generating device called is manufactured by the company, Novocure. Optune is approved in the United States and Europe for the treatment of newly diagnosed and recurrent glioblastoma multiforme, or GBM, and is undergoing clinical trials for several other tumor types.
Optune is a wearable and portable, FDA-approved device that has been shown in clinical trials to safely deliver continuous therapy to the area of your brain where your GBM tumor is located.
Optune delivers therapy through 4 adhesive patches, called transducer arrays. These transducer arrays are applied to your scalp and are connected to the device and battery.
Our researchers and medical doctors are collaborating with scientists and physicians all over the world who are working to find better treatment options, and ultimately a cure, for brain cancer. Some of the most exciting trials are being hosted right here at the Preston A. Wells Jr. Center for Brain Tumor Therapy, including several trials that are being implemented for people for the first time. Some of the most unique trials in the world are being led by researchers and doctors here on our campus.
ÍøºìºÚÁÏ research scientists make medicine better every day. They discover new ways to help people by running clinical trials. When you join a clinical trial, you can get advanced medical care. Sometimes years before it's available everywhere. You can also help make medicine better for everyone else. If you'd like to learn more about clinical trials, visit our clinical trials page. Or click one of the links below:
The primary objective will be to demonstrate the manufacturing feasibility and safety, and to determine the maximum tolerated dose (MTD) of RNA-LP vaccines in (Stratum 1) adult patients with newly diagnosed GBM (MGMT low level or unmethylated in…